Why the study?
Does nimodipine improve neurologic outcomes in patients with mild to moderate acute ischemic stroke?
Population
52 patients with acute ischemic stroke of mild or moderate severity, with treatment started within 48 hours…
Comparison
Nimodipine 30 mg orally q.i.d. for 14 days. vs Placebo.
Design
RCT, randomized, double-blind
Follow-up
4 months
Authors
Loading...
Nimodipine should not be used in mild-moderate acute ischemic stroke; confirms lack of benefit on neurologic recovery.
Does nimodipine improve neurologic outcomes in patients with mild to moderate acute ischemic stroke?
Oral nimodipine initiated within 48 hours of symptom onset did not improve neurologic recovery in patients with mild to moderate acute ischemic stroke.
Bogousslavsky et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: